Lives saved and financial risk protectionfrom scaling up kangaroo mother care in India: an extended cost -effectivenessanalysis
Open Access
- 2 September 2026
- journal article
- Published by BMJ in BMJ Global Health
- Vol. 11 (9) , e021719
Abstract
Introduction: Kangaroo mother care (KMC) is a proven, low-cost intervention to reduce neonatal mortality, yet its coverage remains limited in most low- and middle-income countries (LMICs), including India. In this study, we examined the impact of scaling up KMC in India on distribution of health and financial outcomes using an extended cost-effectiveness analysis (ECEA) framework. Methods: Building on primary data from a randomised controlled trial (RCT), we modelled the health and financial outcomes of scaling up KMC to 95% coverage nationally. We estimated lives saved, disability-adjusted life-years (DALYs) averted, out-of-pocket expenditure (OOPE) averted and cases of catastrophic healthcare expenditure prevented. Estimates were disaggregated by socioeconomic quintiles and geography. We used deterministic and probabilistic sensitivity analyses to assess the robustness of our findings. Results: Scaling up KMC in India could save around 26 000 neonatal lives annually, avert approximately 1.6 million DALYs, reduce OOPE by around US$13 million and prevent an estimated 57 000 households from experiencing catastrophic health expenditures. Three-fourths of the benefits would be concentrated in the lowest two socioeconomic quintiles. Six high-burden states, including Uttar Pradesh, Bihar and Madhya Pradesh, accounted for 90% of the health and financial gains. The incremental cost-effectiveness ratio ranged from 0.08 to 0.17 times gross domestic product per capita for India across different quintiles. Probabilistic sensitivity analysis showed scaling up KMC would be cost-effective in 97.8% of simulations. Conclusion: Our findings suggest that scaling up KMC is cost-effective and can reduce health inequities, particularly benefiting the lowest socioeconomic groups and high-burden states. Incorporating geographical disaggregation and using primary RCT data into ECEA enhance its utility for informing evidence-based, equity-focused health policies in LMICs.Keywords
Funding Information
- Norwegian Research Council (RCN) through its Centres of Excellence scheme and the University of Bergen to the Centre of Intervention Science in Maternal and Child Health (project no. 223269)
- Norwegian Research Council (RCN) Centre of Excellence grant to the Bergen Centre for Ethics and Priority Setting (project no. 332673)
- Norges Forskningsråd (EquiFinance (project no. 316354))
This publication has 25 references indexed in Scilit:
- Development of the Indian Reference Case for undertaking economic evaluation for health technology assessmentThe Lancet Regional Health - Southeast Asia, 2023
- Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic EvaluationsValue in Health, 2022
- A systems model of SDG target influence on the 2030 Agenda for Sustainable DevelopmentSustainability Science, 2021
- Effect of community-initiated kangaroo mother care on survival of infants with low birthweight: a randomised controlled trialThe Lancet, 2019
- Progress on catastrophic health spending in 133 countries: a retrospective observational studyThe Lancet Global Health, 2018
- Progress on impoverishing health spending in 122 countries: a retrospective observational studyThe Lancet Global Health, 2018
- Health Inequities in India2018
- Extended Cost-Effectiveness Analysis for Health Policy Assessment: A TutorialPharmacoEconomics, 2016
- Public finance of rotavirus vaccination in India and Ethiopia: An extended cost-effectiveness analysisVaccine, 2013
- Health economic evaluation: Important principles and methodologyThe Laryngoscope, 2013